Recall events
/
Event 87712
Event summary
Timeline bucket April 08, 2021
Product types Drug
Classifications Class I
Statuses Ongoing
Recalling firm wording NSNY Distributor Inc
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Premium OrgaZEN 7000 capsule, 1-count per blister card, distributed by: Nutra Vita Co, Santa Fe Springs, CA, Made in USA , UPC 0 40232 32555 7
D-0641-2021
Recall number D-0641-2021
Initiated April 08, 2021
Classification Class I
Status Ongoing
Quantity 2600 capsules
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil
Distribution pattern USA Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12839]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
Ginseng Power 5000 capsule, 1- count per blister card, GS Natural Co, Los Angeles, CA 90010, UPC 0 40232 18144 3
D-0642-2021
Recall number D-0642-2021
Initiated April 08, 2021
Classification Class I
Status Ongoing
Quantity 399 capsules
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/ or tadalafil
Distribution pattern USA Nationwide
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13015]
FDA event record
· Exact recall-number query on openFDA
